Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy : the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.

Keyword

Aged

Aged; 80 and over

Antihypertensive Agents/*pharmacology/therapeutic use

Atenolol/pharmacology/therapeutic use

Diabetes Complications/drug therapy/mortality/physiopathology

Diabetes Mellitus/mortality/*physiopathology

Double-Blind Method

Electrocardiography

Female

Humans

Hypertension/drug therapy/mortality

Hypertrophy; Left Ventricular/*drug therapy/mortality

Losartan/pharmacology/therapeutic use

Male

Middle Aged

Prognosis

Treatment Outcome

Publication and Content Type

ref (subject category)

art (subject category)